// App-Quantinova.ai

361 : Gene Expression Pathways Modulated by Anifrolumab in Systemic Lupus Erythematosus

Researchers

Presenter

  • Tina Baker

Principal Investigators

  • Sharifian Hoda

  • Paul Newcombe

  • Mark Lazarus

  • Madhu Ramaswamy

  • Nicola Ferrari

  • Daniel Muthas

  • Hussein Al-Mossawi

  • Raj Tummala

  • Eric F. Morand

  • Richard A. Furie

  • Edward Vital

  • Philip Brohawn

Medical Centers

  • Astra Zeneca, Cambridge, United Kingdom

  • AstraZeneca, Gothenburg, Sweden

  • AstraZeneca, Gaithersburg, MD

  • Deakin University, Melbourne, Australia

  • Northwell Health, Great Neck, NY

  • University of Leeds, Leeds, United Kingdom

Locations

  • United Kingdom

  • Sweden

  • United States

  • Australia

Companies

  • N/A

Study Components

Therapeutic Area

  • Autoimmune (AI)

Disease

  • Lupus

Biomarkers

  • Albumin/creatinine

Drug/Treatment

  • Glucocorticoid

  • MDX1333

Outcome

  • N/A

Study Design

  • Placebo Control

Phase

  • III

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved